Caesar Zuniga
Foot Surgery · El Paso, TXNPI 1063473254
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Stryker accounts for 72.7% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $411 and has fallen 54.8% since, to $186 in 2025. That places this record below the midpoint for foot surgery clinicians in TX, where the typical reported total is $2,095.
Across 41 payments — averaging $31.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$950
- DJO, LLC$326
- Amgen$16
- Misonix Inc$15
What the payments were for
- Food & beverage$1,308100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 12 | $950 |
| DJO, LLC | 27 | $326 |
| Amgen | 1 | $16 |
| Misonix Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALLOMATRIX$141
- ACTISHIELD CF$114
How this compares
$1,308 in reported general payments places this provider in the 40th percentile of 71 foot surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 19 | $25,568 |
| Ciclopirox | 187 | $6,667 |
| Ammonium Lactate | 247 | $4,043 |
| Diclofenac Sodium | 88 | $3,080 |
| Mupirocin | 225 | $2,360 |
| Terbinafine Hcl | 112 | $1,160 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 46 | $864 |
| Methylprednisolone | 106 | $840 |
| Cephalexin | 123 | $642 |
| Clindamycin Hcl | 28 | $186 |
| Meloxicam | 35 | $177 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $102 |
| Tramadol Hcl | 14 | $81 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in El Paso
- Paul ResignatoEl Paso$7K
- George AlvaradoEl Paso$7K
- Gerald McCoolEl Paso$1K
- Marque AllenSan Antonio$204K
- James JacobsKaty$81K
- Lawrence LaverySan Antonio$59K
- Robert GraserBoerne$54K
- Richard KehSan Antonio$17K
- Chad ClauseWebster$17K
- Seth AshrafSan Antonio$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.